Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Researchers at the Eye Clinic of the University Hospital Bonn (UKB) and the University of Bonn have found a promising imaging monitoring method utilizing optical coherence tomography angiography (OCTA). The technique assesses blood flow in retinal vessels, revealing crucial insights…

COVID-19, a global pandemic caused by the SARS-CoV-2 virus, has affected nearly every aspect of healthcare, including eye care services. Since the virus was first identified in December 2019, it has caused significant disruptions in healthcare systems worldwide. This article…

Micro Labs, based in Bengaluru, announced the launch of Trisopt, the world’s first fixed-dose combination (FDC) to include Brimonidine, Timolol, and Brinzolamide in an ophthalmic suspension, designed specifically for the management of glaucoma. The drug is manufactured within Micro Labs’…

Early Retinal Imaging: The Beginnings of Ophthalmic Photography Early retinal imaging — The origins of (retinal) ophthalmic photography go back around 150 years when Drs Jackman and Webster, in the USA, published the first robust account of capturing images of…

In our daily lives, we usually take our eyesight for granted and avoid going to see a professional regularly. Our eyesight is one of the most valuable assets that we have. There are hundreds of different eye diseases and conditions.…

A recent study led by investigators from Mass Eye and Ear has found a concerning association between the use of semaglutide, prescribed for diabetes and weight loss under brand names Ozempic and Wegovy, developed by Novo Nordisk, and an increased…

Researchers at the University of Connecticut (UConn) have identified a potentially transformative factor for regenerating damaged optic nerves, which could ultimately prevent irreversible blindness. This discovery is published in the May 2024 issue of Experimental Neurology. The Impact of Optic…

CHA Hollywood Presbyterian Medical Center, a member of CHA Health Systems, announced that Dr. Rohit Varma, the Founding Director of its cutting-edge Southern California Eye Institute, has successfully implanted the world’s first Calibreye System, a next-generation glaucoma drainage device, into…

Mediwhale, an AI-driven diagnostics company, has successfully raised $12 million in Series A2 funding to further develop its retina scanning technology aimed at diagnosing cardiovascular and metabolic diseases. This round was led by the Korea Development Bank, with contributions from…

Statins, a class of lipid-altering drugs, have revolutionized the treatment of hypercholesterolemia and are instrumental in both primary and secondary prevention of cardiovascular disease (CVD). As the most commonly prescribed cholesterol-lowering medications, understanding their effects on eye health, particularly concerning…